Molecular fingerprints point the way to earlier cancer diagnosis and more targeted treatment

March 24, 2009

Metabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer.

You've likely heard about metabolites; your physician probably screens for some known ones such as triglycerides or cholesterol at your annual physical. Scientists suspect we have about 3,000 metabolites that come from our food or are synthesized from different compounds in our bodies.

Dr. Sreekumar, a cancer researcher at the Medical College of Georgia Cancer Center, wants those screens of the blood or urine to also detect early signs of cancers such as leukemia, bladder, kidney and breast when the chance for cure is best.

He's already begun to identify metabolites that indicate not only the presence of prostate cancer, but its aggressiveness, a tool that could help tailor optimal treatment. The search began in men at risk: those with elevated prostate specific antigen, or PSA, levels. A PSA test along with a digital rectal exam is today's standard for prostate screening so physicians typically do both in men age 50 and older. But PSA levels are actually better at helping determine if prostate cancer has returned, Dr. Sreekumar says.

Elevated levels of PSA, a protein, are not always predictive of cancer, which means a lot of men get unnecessary biopsies. PSA measurements also can't distinguish between tumors that have a good outcome versus those with a poor one.

"The physician does not really have the tools in hand to really say that this tumor will spread to other organs or not." says the Georgia Cancer Coalition Distinguished Cancer Scholar. "We want to find clinical markers that supplement PSA."

Aggressiveness is a major factor in prostate cancer treatment. In fact some men with slow growing disease likely won't even need treatment. So he wants to provide a complement of biomarkers that accurately diagnose and categorize the disease then help monitor success of treatment. These early studies indicate a urine test may one day be possible to do just that.

He and colleagues at the University of Michigan reported in the Feb. 12 issue of Nature what appears to be one of the first metabolites implicated in cancer invasion. They looked at 1,126 metabolites in 262 samples taken from men with high PSA levels. They consistently found elevated levels of the amino acid sarcosine in the prostate tissues of men with cancer; levels were highest in what appeared to be the most aggressive tumors.

Sarcosine, a modified form of the amino acid glycine, was a known entity but its function was unclear. Scientists thought it might be a dumping ground for excess methyl groups needed to enable chemical changes of genes, proteins and other body components that can affect what and how much they do.

This process called methylation can be a good thing - like when it's helping an embryo develop - but when it goes badly, it can cause disease such as cancer. While sarcosine's dumping role seemed to protect from cancer, the Michigan scientists found its action actually helps induce tumors. In fact, when they added it to prostate cancer cells, the cells became more aggressive. Exactly how that process works is still under study but the findings were pretty consistent.

"When we looked at patients with metastatic disease, sarcosine levels were sky high compared to patients with localized tumors," says Dr. Sreekumar. "It's enabling invasion."

Because cancer and people are both very heterogenous, measures need to be taken in larger population samples, he says. Also, they found a small group of patients with negative biopsies and high sarcosine levels. "We don't know how many of them have missed cancer," says Dr. Sreekumar who joined the MCG faculty in February.

These are among the reasons he believes in strength in numbers. "In the real world of biomarkers, you want 100 percent sensitivity. If the patient has cancer, you want to pick it up. We need to have a kind of multiplex test where you can test for say10 different entities and have a greater confidence that what you are stating about the tumor is true. Our goal is to develop such a panel and research on sarcosine is a first step toward achieving this."

In his new position at MCG, he's looking to expand the number of metabolites known to be predictive of prostate and other cancers. In prostate cancer, he's beginning with follow up on other metabolites identified in the Michigan study in which researchers identified a total of six metabolites, including sarcosine, linked to increased tumor progression. A total of 89 metabolites were different in metastatic prostate cancer compared to localized disease.

He's excited about what metabolites will one day tell cancer physicians and patients but adds that they are just a piece of what our bodies can tell us about a potential cancer growing inside. Scientists also need to continue to look at genes expressed by tumors and the proteins expressed by those genes to get the bigger picture. "It's basically a systems approach you need to take," he says.

The young scientist has worked with all those pieces in his relatively short career. He started his postdoctoral fellowship at the University of Michigan in1999, when the ability to look at gene expression was new. With his mentor, Dr. Arul M. Chinnaiyan, director of Michigan Center for Translational Pathology, Pathology Research Informatics and Cancer Bioinformatics at Michigan, he helped develop the next step: the ability to look at expression of hundreds of proteins at a time, instead of a handful, an important advance in light of the fact that there are about 1 million proteins. Recently they were among the first to venture into the world of metabolites, which are made by proteins.

"Previous technology was looking at a cell from a narrow perspective and cells never act in isolation, proteins never act in isolation, they always form complexes, act in pathways," Dr. Sreekumar says.

His inspiration to follow those pathways is a fellow Ph.D. student who died too young and quickly of an aggressive leukemia and the fact that cancer is a leading cause of death worldwide.

Medical College of Georgia

Cancer Diagnosis: What to Do Next
by W. John Diamond (Author)

The complete guide to early detection and prevention of cancer and with proven safe and nontoxice treatments.

Artificial Epidemics: How Medical Activism Has Inflated the Diagnosis of Prostate Cancer and Depression (Kindle Single)
by Now and Then Reader, LLC

“Early detection” has become a cardinal principle of medical treatment in our time. But how effective is it in controlling two conditions that have reached near-epidemic proportions in the United States—prostate cancer and depression?

In this trenchant appraisal of what he calls medical activism, Stewart Justman describes how the quest for early detection has led to mass screenings, which in turn have revealed an incidence of disease that is beyond common sense and cautious medical practice. The entire process has led to patients who have been not helped but damaged.

Stewart Justman’s books include "Seeds of Mortality," a reflection on cancer and culture that received the PEN Award for the Art of the Essay; "Fool’s Paradise," an exploration of self-help...

Prostate and Cancer: A Family Guide to Diagnosis, Treatment, and Survival
by Sheldon Marks MD (Author)

Prostate cancer is one of the most common cancers affecting American men, with over 186,000 new cases diagnosed in the United States annually; 1 in 6 men will be diagnosed with prostate cancer during his lifetime. Renowned prostate cancer specialist Sheldon Marks offers the definitive guide for men concerned about or diagnosed with prostate cancer, and for their families.Since the third edition (2003), there have been significant changes in treatment and resources. Working with Dr. Judd Moul, the Chairman of Urology at Duke and one of the world’s top experts on prostate cancer, Marks provides the most up-to- date information on diagnosis, treatment, and common questions.

Lung Cancer: A Guide to Diagnosis and Treatment
by Walter J. Scott MD (Author)

What is my prognosis? What are my treatment options? Which therapies would be the most effective for my stage of lung cancer? These and other frequently asked questions are addressed in this crucial reference designed to help patients educate themselves and obtain the best possible treatments. The completely revised second edition has been updated to include a discussion of the movement towards customized chemotherapy; treatment options for early-stage lung cancer including minimally invasive surgery; and the most promising treatments, among them multimodality therapy—a combination of surgery, chemotherapy, and radiation. Dr. Scott also surveys tests for early detection of lung cancer, talks about the importance of cancer staging, examines alternative treatments, and offers advice on...

Gynecologic Tumor Board: Clinical Cases in Diagnosis and Management of Cancer of the Female Reproductive System
by Don S. Dizon (Author), Nadeem R. Abu-Rustum (Author)

Gynecological Tumor Board is a comprehensive reference on clinical management of reproductive system cancers in women. Twenty nationally recognized leaders in the field of Gynecologic Oncology present cases from diagnosis through medical/surgical treatment through QOL and long-term care that reflect the clinical scenarios often found in the Gynecologic Oncology clinic, and present the best current guidelines for treating those conditions. Special Editors' Comments provide expert analysis and counterpoint to the cases.

Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages - Revised Edition - Illustrated by S. Smith
by Department of Health and Human Services (Author), National Institutes of Health (Author), National Cancer Institute (Author), S. Smith (Editor), S. Smith (Editor)

This Cancer Book is the revised version of the popular original version titled "Cancer Causes, Symptoms, Signs, Diagnosis and Treatments", written by the: U.S. Department of Health and Human Services (Author), National Institute of Mental Health (Author), (Author), National Institutes of Health (Author) and S.Smith (Editor) and (Illustrator) This book has been professionally illustrated and edited with a fully hyper-linked table of contents for ease of navigation. A detailed booklet that describes Cancer, symptoms, causes, and treatments, with information on getting help and coping. This booklet is also for family and friends that are looking for further understanding of Cancer. You will learn in this Booklet: Introduction Understanding Cancer Risk Factors Screening Symptoms Diagnosis...

Reclaiming Your Life After Diagnosis: The Cancer Support Community Handbook
by Kim Thiboldeaux (Author), Mitch Golant (Author), Mehmet Oz (Foreword)

A Comprehensive and Compassionate Approach to Cancer Care

Reclaiming Your Life After Diagnosis is packed with incredible information and resources to get you or someone you love through the challenging journey of a cancer diagnosis and treatment. This book accurately and compassionately addresses the physical, emotional, social and practical needs of cancer patients and their support systems.

Find out how to:

Put an effective support and resource team in place to buffer against the challenges of diagnosis and treatment
Build a community to deal with the daunting decisions treatment requires
Develop practical, more effective ways to manage side effects
Deal with complex emotional issues ranging from the shock of initial diagnosis to creating a living legacy...

Straight Talk About Breast Cancer: From Diagnosis to Recovery
by Suzanne W. Braddock MD (Author), Jane M. Kercher MD (Author), John J Edney MD (Author), Melanie Morrissey Clark (Author)

This medical handbook serves as an accessible resource for answering the questions of women with breast cancer as well as easing the concerns of their spouses and family members. Drawing on the personal experiences of a breast-cancer survivor and the professional expertise of breast-cancer specialists, this guide outlines the various treatment options for cancer patientsincluding lumpectomy and mastectomy surgeries, radiation treatment, and chemotherapyboth in terms of how they work and the toll they take on a patient’s life. Photographs on breast reconstruction are included as is a complete list of resources and an open discussion of hereditary and reoccurrence risks. The latest information on diagnostics and treatment is provided, making this an essential resource for those...

Cancer Of The Uterus: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages Of Cancer of the Uterus - Revised Edition - Illustrated by S. Smith
by Department of Health and Human Services (Author), National Institutes of Health (Author), National Cancer Institute (Author), S. Smith (Editor), S. Smith (Editor)

This Cancer of the Uterus Book is the revised version of the popular original version titled "Causes, Symptoms, Signs, Diagnosis, Treatments, Stages Of Cancer of the Uterus ", written by the: U.S. Department of Health and Human Services (Author), National Institute of Mental Health (Author), (Author), National Institutes of Health (Author) and S.Smith (Editor) and (Illustrator) This book has been professionally illustrated and edited with a fully hyper-linked table of contents for ease of navigation. A detailed booklet that describes Causes, Symptoms, Signs, Diagnosis, Treatments, Stages Of Cancer of the Uterus, with information on getting help and coping. This booklet is also for family and friends that are looking for further understanding of Cancer of the Uterus. You will learn in this...